Binx Io
The binx io CT/NG cartridge contains reagents for detecting Chlamydia trachomatis and Neisseria gonorrhoeae DNA with the binx io instrument. It uses female vaginal swabs collected in a…
The binx io CT/NG cartridge contains reagents for detecting Chlamydia trachomatis and Neisseria gonorrhoeae DNA with the binx io instrument. It uses female vaginal swabs collected in a clinical setting or male urine specimens to aid diagnosis in symptomatic or asymptomatic patients.
Within the cartridge, sample preparation releases and purifies DNA, PCR amplifies target sequences, and electrochemical detection identifies the amplified material. The instrument controls fluid movement through cartridge valves and reports a qualitative result.
Listed Item
binx io CT/NG cartridge
Process Control
An internal process control passes through extraction, amplification and detection with the specimen and checks the validity of negative results. A symptomatic male patient with a negative chlamydia result should receive further testing with a laboratory molecular test.
Who Else Makes It
Registered in Guangdong. One is registered as a contract manufacturer, able to build to a specification.
| Manufacturer | City | Province | Registered as | Device types |
|---|---|---|---|---|
| Hochuen Medical Technology Co., Ltd. | Shenzhen | Guangdong | Contract manufacturer | 20 |
Record
| Listed by | Binx Health, Ltd., United Kingdom |
|---|---|
| FDA product code | QEP |
| Device type | Nucleic Acid Detection System For Non-Viral Microorganism(S) Causing Sexually Transmitted Infections |
| Device class | Class 2 |
| Regulation | 21 CFR 866.3393 |
| Establishment | Manufacturer |
| 510(k) | K200533 |
| Record published | 2025-09-03 |
Specifications
| MRI safety | Labeling does not contain MRI Safety Information |
|---|---|
| Single use | Yes |
| Prescription | Prescription only |
| Label carries | lot or batch number, expiry date |
| Packaging | Shipper of 50 |
Catalogue Numbers
| Catalogue number | Size | Status |
|---|---|---|
| V1 (CT/NG) | In distribution |
Same Product Code
| Product | Sold by | Catalogue numbers |
|---|---|---|
| Aptima | Hologic, Inc. | 5 |
| Alinity m | Abbott Molecular, Inc. | 4 |
| Xpert CT/NG | Cepheid | 2 |
| cobas® TV/MG | Roche Molecular Systems, Inc. | 2 |
| Aptima Combo 2® | Hologic, Inc. | 2 |
| cobas® TV/MG Positive Control Kit | Roche Molecular Systems, Inc. | 2 |
| Visby Medical Men’s Sexual Health Test | Visby Medical, Inc. | 1 |
| BD COR CTGCTV2 US | Becton, Dickinson AND Company | 1 |
510(K) Clearances
| Clearance | Decision date |
|---|---|
| K200533 | 2020-04-27 |
| K191352 | 2019-08-08 |
Recalls Naming This Product
1 recall names this product by its own identifier, the 510(k) it is cleared under.
| Recalled by | Identified by | Initiated | FDA class | Root cause | Reason | Quantity |
|---|---|---|---|---|---|---|
| Binx Health, Ltd. | 510(k) number | 2023-03-29 | Class II | Under Investigation by firm | May not meet the declared performance characteristics for the detection of Chlamydia trachomatis (CT) within the labeled expiry period, potential to produce either false negative CT or positive CT results | 50 single-use cartridges |
Source: U.S. FDA establishment registration and device listing records, public domain. Restructured for clarity and searchability. Not affiliated with or endorsed by the FDA. Records are records: nothing here is an offer of sale.